Moderna in $35 million licensing deal with CytomX
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
US scientists have developed a low-cost way to harvest waste energy from visible light communication by using the human body as an antenna.
Dabur India, an ayurvedic and natural healthcare company, forecasts a low to mid-single-digit revenue growth for the third quarter ending December 31 due.
Global cold spells and frost days are set to fall as New Year temperatures soar above 20 degrees Celsius in European nations, according.
Investigators from India's Director General of Trade Remedies have started an anti-dumping probe into vitamin A palmitate imports from China, the EU and.
Constant checking of social media posts response affects neural development in teens
More than 700,000 nurses in the UK's National Health Service (NHS) will go on strike this month following a dispute with the government over salaries.
Spain passes plastic waste decree that will force tobacco companies to clean up cigarette butts from public spaces
There is a predominance of Omicron BA. 5.2 and BF.7 Covid-19 lineages, accounting for 97.5% of all local infections in China, according to.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com